2019
DOI: 10.1016/j.ophtha.2018.08.009
|View full text |Cite
|
Sign up to set email alerts
|

Spectral-Domain OCT Measurements in Alzheimer’s Disease

Abstract: Our results confirmed the associations between retinal measurements of SD OCT and AD, highlighting the potential usefulness of SD OCT measurements as biomarkers of AD.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

12
273
2
2

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 266 publications
(301 citation statements)
references
References 181 publications
(249 reference statements)
12
273
2
2
Order By: Relevance
“…These results provide an in vivo validation for that which was previously observed ex vivo by Perez et al 44 In future studies, the inner and outer retina could be subdivided further to quantify individual layer thickness. Since RNFL thinning occurs in AD patients, 28,29 it may also be interesting to quantify the RNFL thickness alone in this mouse model. However, quantifying the RNFL thickness in mice using OCT is difficult, as the peripapillary thickness of the healthy RNFL is only approximately 20 µm, 74 and is interrupted by blood vessels and ganglion cells.…”
Section: Cortical Amyloid Beta Plaque Loadmentioning
confidence: 99%
See 1 more Smart Citation
“…These results provide an in vivo validation for that which was previously observed ex vivo by Perez et al 44 In future studies, the inner and outer retina could be subdivided further to quantify individual layer thickness. Since RNFL thinning occurs in AD patients, 28,29 it may also be interesting to quantify the RNFL thickness alone in this mouse model. However, quantifying the RNFL thickness in mice using OCT is difficult, as the peripapillary thickness of the healthy RNFL is only approximately 20 µm, 74 and is interrupted by blood vessels and ganglion cells.…”
Section: Cortical Amyloid Beta Plaque Loadmentioning
confidence: 99%
“…26,27 Retinal layer thinning, particularly in the retinal nerve fiber layer (RNFL), is also present in the retina of AD patients. 28,29 However looking forward to a marker for diagnosis, RNFL thinning is not specific to AD and it is not only associated with other diseases such as glaucoma 30 and Parkinson's disease, 31 but also more generally with increasing age. 32 With many contradictory observations, it is clear that there is still a great deal of research to be performed in order to fully understand the effects of AD on the retina.…”
Section: Introductionmentioning
confidence: 99%
“…Beyond ophthalmology, there is also potential for SD‐OCT retinal images to provide biomarkers for disease. In particular, multiple studies have noted the potential of SD‐OCT to provide a biomarker for neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and frontotemporal degeneration (FTD) . Studies have also applied SD‐OCT to evaluate retinal thickness associations with cognitive decline, particularly in large data sets .…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, OCTA is capable of measuring retinal capillary beds at distinct depths, separating the super cial capillary plexuses (SCP) and deep capillary plexuses (DCP), each re ecting the metabolic demand of particular neuronal layers. [5] In AD, the tissue of interest is the inner retinal layer, as re ected by the loss of retinal ganglion cells, [7,8] thinning of the retinal nerve bre layer thickness and ganglion cell layer thickness, [9] and deposition of β-amyloid (Aβ) plaques. [10] While there are a few OCTA studies investigating AD, there have been mixed conclusions.…”
Section: Introductionmentioning
confidence: 99%